All Business articles – Page 16
View all stories with this category.
-
OpinionDrug pricing must be more transparent
Pricing is a complex issue - how can we make it clearer?
-
Business
European Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified
-
Business
GE accused of exposing workers to toxic chemicals
Canadian union says dangerous compounds were used without proper worker protection
-
Business
Huntsman and Clariant agree merger deal
Uniting Huntsman’s bulk materials with Clariant’s additives gives a more integrated speciality chemicals offering
-
Business
Seattle Genetics cancels Immunomedics deal
Settlement also resolves disputes with shareholders
-
Opinion
How safe should drugs be?
What does spotting new risks in approved medicines say about how effective regulators are?
-
Business
Pollution from Indian drugmakers drives drug resistance
Areas around manufacturing sites still heavily contaminated with antimicrobials and breeding multidrug-resistant pathogens
-
Business
Patheon buyout brings Thermo into contract manufacturing
$7.2bn deal expands Thermo Fisher’s laboratory products and services segment
-
News
Legal battles stall US biosimilars
Unclear legislation and lack of regulatory guidance means companies are turning to the courts
-
Business
Avantor to buy VWR for $6.4bn
Deal continues trend of consolidation in laboratory supplies sector
-
Business
US Steel plant spills chromium into waterway
Pipe failure releases 135kg of hexavalent chromium into Lake Michigan tributary
-
Business
J&J fights talc cancer claims
Firm has lost several court cases linking talc to ovarian cancer, but vows to appeal
-
Business
Merck KGaA to buy Chematica
Retrosynthesis tool will gain computational muscle and integrate with Sigma–Aldrich catalogue
-
Business
BP to sell Chinese joint venture stake to Sinopec
Oil giant retains significant investment in China, but is shifting focus
-
Business
Russia invests in speciality chemicals industry
Government will pump cash into sector to develop domestic industry, counteract effects of sanctions, and meet demand from military
-
Business
India probes Roche over biosimilars
Mylan and Biocon claim Roche abused its market dominance to quash generic breast cancer antibodies
-
Business
Farmers sue to block Syngenta–ChemChina merger
Planned takeover will decrease competition, leading to higher costs and fewer options for farmers
-
Business
Brexit raises regulatory worries
Risk of doubling legal burden for industry undermines referendum’s ‘red-tape cutting’ claims
-
Business
China approves BMS’s hepatitis C drugs
Combination is first all-oral treatment in China, where Gilead’s Sovaldi is not yet approved
-
Opinion
Crystal clear
The dark craft of crystallisation is an essential skill when working on kilogram scale
